Aviceda Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Aviceda Therapeutics is a clinical-stage biotechnology company focused on developing immunomodulatory therapies through glycobiology, aiming to address innate immune pathways and chronic, non-resolving inflammation. Its work centers on engineering glyco-immunotherapies that target ocular and systemic degenerative, fibrotic, and immuno-inflammatory diseases, with a delivery approach that uses modular biodegradable nanoparticles to maximize therapeutic durability and efficacy. The company integrates high-throughput screening to identify ligands with high affinity and specificity for innate immune cells, followed by conjugation to its nanoparticle system to create candidate medicines. Based in Cambridge, Massachusetts, Aviceda positions itself in the biopharma research space as a developer of next-generation immune-modulating medicines, leveraging a platform they describe as highly adaptable for a broad range of immuno-inflammatory indications.
1-888-653-2347 
support@leadiq.com 
